Neopharm Labs Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 865 boul Michele-Bohec, BLAINVILLE, QUEBEC J7C 5J6, Canada (CAN)
- Operations here
- analysis
- FDA identifiers
- FEI 3002807703 · DUNS 243379372
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-09-12
- NAIDrug Quality Assurance2019-03-19
- NAIDrug Quality Assurance2018-02-09
- NAIDrug Quality Assurance2014-11-14
- NAIDrug Quality Assurance2012-05-01
- NAIDrug Quality Assurance2010-02-16
Drugs this plant is listed as making
2 distinct drugs across 8 products name this site in their FDA label.
- methotrexatein shortageAntares Pharma, Inc.
- sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphateLukare Medical, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.